June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 27, 2025

CGM Boosts Wound Healing, Lowers A1c: Study

Short-term CGM use improved A1c, wound healing, and reduced ED visits in diabetic foot patients, per data from ADA’s 85th Scientific Sessions.

Conexiant

June 27, 2025

Weight Loss Drugs, Heavier Implications

New guidance positions GLP-1 and GLP-1/GIP therapies as frontline options for long-term weight management—with profound implications for cardiovascular outcomes, access equity, and chronic disease care.

Conexiant

June 27, 2025

Ecnoglutide Shows Strong Weight Loss in Trial

A once-weekly GLP-1 receptor agonist, ecnoglutide, led to significant and sustained weight loss in a large study of adults with overweight or obesity, with favorable safety outcomes reported at the ADA’s 85th Scientific Sessions.

Conexiant

June 27, 2025

New Guidance Targets Risk-Based Diabetes Care

A new review outlines updated strategies for diagnosing and managing type 2 diabetes, recommending earlier use of SGLT2 inhibitors and GLP-1 receptor agonists in patients with cardiovascular or kidney conditions.

Conexiant

June 27, 2025

MASLD Linked to Sudden Hearing Loss

New research links a common metabolic liver condition in older adults to elevated risk of sudden hearing loss, highlighting potential implications for screening and prevention.

Conexiant

June 26, 2025

Is Alternate-Day Fasting Most Effective?

A review of 99 randomized trials found that all intermittent fasting and calorie-restricted diets reduced body weight, with alternate day fasting offering the most benefit over other strategies in short-term studies.

Conexiant

June 25, 2025

Ultrasound Finds Early Insulin Resistance Signals

A handheld ultrasound probe could soon help detect metabolic issues long before blood sugar levels raise concerns.

Conexiant

June 25, 2025

Does Tirzepatide Rapidly Reduce Appetite?

GLP-1/GIP dual agonist demonstrates rapid neurobiological effects on appetite regulation and food reward pathways

Conexiant